© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
416246 |
As an accredited (R)-1-(3-Bromophenyl)Ethanol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive (R)-1-(3-Bromophenyl)Ethanol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In today’s laboratories and industrial sites, a growing wave of interest surrounds (R)-1-(3-Bromophenyl)Ethanol. As chemists seek greater control over the outcomes of their reactions, this specific chiral building block offers a reliable foundation for new drug synthesis and fine chemical exploration. The molecule’s value doesn’t just rest in a list of technical specs—it comes alive in the hands of researchers eager to break new ground in life sciences and specialty materials.
I’ve seen plenty of labs struggle with inconsistency when sourcing building blocks for stereoselective synthesis. Using an enantiopure compound like (R)-1-(3-Bromophenyl)Ethanol, chemists bridge a gap—they skip trial runs, knowing that the chirality and purity feed right into downstream transformations. As someone who’s handled batches with slight enantiomeric mismatches, I’ve witnessed the wasted time, failed reactions, and repeated purifications that drag a project off course.
This compound flows easily into a variety of reactions, and its structure—anchored on a 3-bromophenyl core and an ethanolic group—opens doors to unique derivatives. Lab teams appreciate the consistency in melting point, the lack of weird odors, and ease of incorporation into larger frameworks. Whether scaling a project toward gram quantities or running bench-top trials, supply partners who focus on repeatability really shine here.
Drug discovery continues to move away from one-size-fits-all screening and toward highly tailored molecular design. In this environment, (R)-1-(3-Bromophenyl)Ethanol sets itself apart as a key participant. Chirality is crucial—our bodies only respond to molecules with the right shape, so having confidence that a batch contains only the R-enantiomer isn’t just technical nitpicking. It’s about enabling safer, more predictable outcomes in preclinical trials.
In medicinal chemistry, the bromophenyl motif brings opportunities for targeted functionalization. The ethanol side chain couples easily with protective groups or larger molecules, letting researchers scaffold analogs in series, test bioactivity, and push the boundaries of what a parent structure can achieve. I’ve seen this flexibility allow rapid pivoting between synthetic pathways, saving months that would otherwise fall to dead ends.
Quality in the lab starts with confidence in raw materials. Modern suppliers feel the pull toward greener chemistry, aiming for processes that cut down on solvents and limit emissions without sacrificing batch-to-batch reliability. With chiral reagents like (R)-1-(3-Bromophenyl)Ethanol, analysts rely on precise enantiomeric excess reporting, tight identification specs, and trace impurities documented to sub-ppm levels.
From my own routines in chemical purchasing, I know that paperless traceability is growing more valuable. It isn’t just about regulatory compliance; it’s about establishing a feedback loop, where purity issues can be traced upstream, and improvements push down costs over time. Companies that publish their spectral data openly or invite independent verification build a reputation for trustworthiness.
There’s a world of difference between generic chiral alcohols and those decorated with targeted substituents. The 3-bromo group in this molecule brings a level of reactivity that isn’t available in plainer structures. Nucleophilic substitutions at this position unlock easy access to amines, ethers, or more elaborate functionalities—useful in the discovery of new catalysts, ligands, or pharmaceuticals.
Traditional options demand additional steps or in-house functionalizations, which eat up hours of synthesis, risk contamination, or even cause scale-up headaches. Here, the bromo position comes pre-installed, letting teams leapfrog these bottlenecks. I remember projects where this meant the difference between a straight path to the target molecule and a months-long slog of intermediates.
Controlling stereochemistry at every stage sometimes feels like rolling dice, especially in traditional asymmetric synthesis. The headaches roll in—diastereomeric side-products, tedious chromatographic separation, or ambiguous analytic data that bogs down reports. Working with (R)-1-(3-Bromophenyl)Ethanol gives a solid foundation; research teams access its single enantiomer and sidestep much of the clean-up.
In practice, chemists don’t want to gamble their time or grant money on starting material that underperforms. Markets evolve, deadlines shrink, and getting precisely what’s needed—without unproductive side reactions—spares companies unnecessary waste. The repeatability of this product allows engineers to scale from milligrams to kilograms with fewer surprises, which turns into both cost savings and safer workflows.
Synthetic chemists often value a single building block that adapts to several possible routes. With its dual functionality—a reactive bromide and an alcohol—(R)-1-(3-Bromophenyl)Ethanol lets teams test several approaches on a small scale before settling on a best path. In heterocyclic synthesis, this ability to branch off toward alternative products reduces guesswork and lets researchers rebalance projects on the fly.
I’ve yet to see this kind of flexibility from distilled, racemic alcohols or products without strategic halogenation. The fine control at each reactive position builds room for fine-tuning, making it easier to capture fleeting opportunities or pivot syntheses if early data doesn’t pan out. Over years of bench work, this has proven more valuable than any technical spec listed in a catalog.
Some labs stick with plain phenylethanol or its methylated cousins due to cost or availability. The loss in site-specific reactivity quickly shows up in more steps and more purification headaches. (R)-1-(3-Bromophenyl)Ethanol holds its edge in offering both chiral integrity and targeted synthetic handles. That alone drives it to the front of shortlists for new ligand screening, lead optimization, or targeted delivery research.
Consider a typical pathway for kinase inhibitor discovery. A brominated precursor can follow functionalization and click chemistry pathways with far fewer workups than non-halogenated compounds. The difference appears right on the balance sheet and in the treasury of lab time saved. As research funding continues to tighten, picking materials that do more in less time isn’t just clever—it’s essential.
Most researchers have been burned at least once by a batch of reagent that didn’t live up to its pedigree. I have vivid memories of spending extra hours on NMR and chiral HPLC because contaminants crept in. Suppliers that take pride in characterizing each lot—publishing retention times, mass spectra, and impurity profiles—build a track record of transparency and practical reliability.
For (R)-1-(3-Bromophenyl)Ethanol, repeatable performance isn’t just a numbers game. It shapes the confidence with which a research team plans its entire campaign. Labs waste less time troubleshooting, can focus on creative chemistry, and trust their outcomes as more than a one-off stroke of luck.
As companies and universities rally behind safer, greener synthesis, (R)-1-(3-Bromophenyl)Ethanol fits smoothly into conversations about atom economy and process intensification. The kind of targeted functionality seen here trims away unnecessary steps, avoids redundant byproducts, and lays a clear map toward scaling up. Teams look for supply chain partners who back up sustainability claims with real data—those who shift away from hazardous reagents or update production methods to cut emissions win outsized loyalty.
From my seat in a mid-sized process chemistry team, I watched our group move from trial batches to large-volume production. Direct access to chiral reagents with built-in reactive sites cut both solvent consumption and purification time in half. It lowered the energy draw for downstream reactions, trimming operating costs and giving real evidence behind the sustainability slogans so often plastered in glossy reports.
Working in synthetic labs, surprises pop up. Humidity can crash out a product, unstable intermediates can decompose, or small impurities can trigger odd side reactions. The best materials come from suppliers who answer quickly, share shelf life data, and adjust supply options based on feedback. Many newer sourcing platforms document origins, batch analyses, and comparison data openly, making day-to-day troubleshooting less guesswork and more precise science.
Take storage: moisture compatibility matters, especially with halogenated alcohols. Proper storage solutions—tight seals, light-blocking bottles—help preserve shelf life. In years working with similar compounds, I learned the value of splitting deliveries and keeping primary stocks away from the main bench. Lab teams avoid headaches later, working from aliquots rather than risking whole-bottle exposure.
The value created with a single chiral building block can ripple out far beyond the initial experiment set. Early projects using (R)-1-(3-Bromophenyl)Ethanol spark fresh collaborations in fields as different as agricultural chemistry and materials science. It’s not just pharmaceutical firms getting value here—polymer researchers, molecular electronics groups, and even flavor and fragrance startups dive in.
My own experience with new material ventures showed that access to sophisticated intermediates can pave the way for spinout technologies. A reliable source, robust QA, and access to analytical support make it easier for talent to innovate around a single scaffold and scale up their ideas. The importance here stretches beyond one reaction vial on a researcher’s bench.
Modern chemistry doesn’t stop at the wet lab. As digital inventory systems and lab automation roll out, researchers benefit from materials that come with full characterization data and electronic records. From creating digital twins of reactions to training AI-assisted reaction predictors, high-quality input makes for robust results.
With (R)-1-(3-Bromophenyl)Ethanol, ready access to digital spectra, certificates of analysis, and reactivity records helps researchers push projects into the digital age. It also supports training new team members, easing knowledge hand-offs as projects grow or change direction. Teams who invest in tight digital-physical integration spot problems faster and control their timelines more effectively.
Method development feels less intimidating with a product whose properties are so well understood. Tweaking reaction conditions, adding protectant groups, or carrying out cross-coupling chemistry with (R)-1-(3-Bromophenyl)Ethanol becomes more about creative risk-taking and less about second-guessing the inputs.
Having been on teams that struggled with stubbornly unreactive substrates, I can appreciate what a difference it makes to start with a track record of responsiveness. Longevity in storage, clarity in purity, and robust documentation open doors for exploratory work—a vital part of keeping research exciting and productive.
Productivity in research depends on the friction—or lack of it—between academic and commercial worlds. (R)-1-(3-Bromophenyl)Ethanol acts as one of those rare materials able to translate across both. Academics enjoy sharing catalysis data or new analog explorations, while commercial enterprises run scale-up validations or apply for regulatory approval.
My own time crossing these worlds highlighted the importance of consistency and reproducibility. New hires learn the ropes more quickly with stable starting materials, and academic groups publish faster, collaborating with industry partners who already use the same intermediates. Pathways open up for sponsored research, joint ventures, and parallel development streams—blurring the lines between theoretical discovery and practical application.
Research communities continuously ask more from their tools and starting points. With advances in data science, combinatorial synthesis, and green chemistry, the expectations for flexibility and dependability rise. (R)-1-(3-Bromophenyl)Ethanol isn’t a magic bullet, but it gives creative people better odds—reliable chirality, targeted functionalization, and support for digital and sustainable science.
Its place in the next wave of molecular innovation stems from qualities that matter in real work environments: transparency from suppliers, well-characterized lots, and a willingness to evolve production in response to customer needs. Researchers want to tell success stories built on the freedom to try bold new approaches, fail gracefully, and pivot quickly—all of which this compound supports.
Standing inside the rhythms of modern life science, specialty chemical development, or academic research, one can see how the right tool shifts the conversation. (R)-1-(3-Bromophenyl)Ethanol brings more to the table than just another reagent. It pulls together reliability, adaptability, and an underpinning transparency—in line with what responsible, forward-thinking science now demands.
Chemistry moves forward on the backs of compounds that offer more than structural intrigue; real breakthroughs come with those that answer practical needs while opening up new technical horizons. (R)-1-(3-Bromophenyl)Ethanol does this by offering direct access to high-value reactivity and dependable chirality joined in one scaffold. It brings down delays, reduces operational risk, and feeds into pipelines where every hour saved can accelerate a discovery to the shelf.
If you’re looking to add strength to your workflow—whether in pharmaceuticals, materials, or synthesis innovation—placing an order for (R)-1-(3-Bromophenyl)Ethanol isn’t just another check on a procurement sheet. It signals a commitment to research integrity, sustainable practice, and the creative agility that drives change. The compound stands ready, not as a magic solution, but as a partner in unlocking the next generation of products and insights.
